Follow me on


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Write a Squawk to pkl
  • Squawk / 08 September 2015 at 13:07 GMT
    Client Experience / Saxo Bank
    Hi all,
    For those interested in technical analysis and stocks, here is a quick technical analysis of the Danish Pharmaceutical company Zealand Pharma (ZEAL:xcse).

    ZEAL experienced an unsustainable upwards move from start juli which culminated in an all-time high of 166.XX on juli 30th.
    From August, ZEAL is forming a series of lower highs and lower lows which indicates an intermediate countertrend. more bearish IKH signals confirm this.

    Going forward:
    The uptrend from october 2014 (green trend line) have had ca. 4 touch-points, which could indicate a strong potential for support. For the same reason I am looking for a clean break and subsequent consolidation below the trend-line in order for me to go short.
    At a bullish break of the downwards channels (blue lines) + bullish IKH signals, I'd look for a good long entry. I'll be looking closely at how volume leading up and following a break to the up- or downside.
    Either way September should be interesting.
    Read the Squawk
    Simon Kjaer Simon Kjaer
    Comments are obviously welcome :)
    pkl pkl
    First you should argue why TA is relevant for Zealand Pharma. Does TA give good predictions for that company - e.g. did you perform a historical analysis?...
    Simon Kjaer Simon Kjaer
    Hi pkl,
    Thank you for your comment. TA is a controversial method of analysis as it never accounts for the fundamental factors of a company or economy....
Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail